Pfizer in Talks to Buy Seagen for upwards of $30B
New York, NY, February 27, 2023 (Reuters) -- Pfizer Inc is in early-stage talks to acquire cancer drugmaker Seagen Inc in a potential multi-billion dollar deal, the Wall Street Journal reported, after advanced discussions between Merck and Seagen fell through last year.
Read full article here.
Comments